111 Inc YI Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$2.90 down $0.08, 2.68% at close Nov 6
Last close · Previous close $2.98
- Market cap
- $25.51MAt the Nov 6 close
- Dividend yield
- NoneLast 12 months
Price chart
$2.90down $0.19, 6.15%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$2.98Nov 5
- Volume56.91KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume18.83KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $2.48 to $11.17; now $2.90
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
YI beat the S&P 500 in 1 of 6 periods.
| Period | YI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | YI: down 6.1% S&P 500: down 5.6% | YI trailed the S&P 500 by 0.5 percentage points Trailed |
| 3M | YI: down 23.5% S&P 500: down 4.1% | YI trailed the S&P 500 by 19.4 percentage points Trailed |
| YTD | YI: up 13.3% S&P 500: up 8.7% | YI beat the S&P 500 by 4.6 percentage points Beat |
| 1Y | YI: down 32.4% S&P 500: up 10.9% | YI trailed the S&P 500 by 43.3 percentage points Trailed |
| Long term | ||
| 3Y | YI: down 87.7% S&P 500: up 75.0% −50.2% vs +20.5% a year | YI trailed the S&P 500 by 162.7 percentage points Trailed |
| 5Y | YI: down 94.4% S&P 500: up 67.8% −43.8% vs +10.9% a year | YI trailed the S&P 500 by 162.2 percentage points Trailed |
$10,000 invested in YI 5 years ago (Nov 5, 2021) would be worth about $560 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,782.
YI beat the S&P 500 in 1 of 6 periods.
| Period | YI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | YI: down 6.1% S&P 500: down 5.6% | YI trailed the S&P 500 by 0.5 percentage points Trailed |
| 3M | YI: down 23.5% S&P 500: down 4.3% | YI trailed the S&P 500 by 19.2 percentage points Trailed |
| YTD | YI: up 13.3% S&P 500: up 7.8% | YI beat the S&P 500 by 5.5 percentage points Beat |
| 1Y | YI: down 32.4% S&P 500: up 9.7% | YI trailed the S&P 500 by 42.1 percentage points Trailed |
| Long term | ||
| 3Y | YI: down 87.7% S&P 500: up 68.8% −50.2% vs +19.1% a year | YI trailed the S&P 500 by 156.5 percentage points Trailed |
| 5Y | YI: down 94.4% S&P 500: up 56.9% −43.8% vs +9.4% a year | YI trailed the S&P 500 by 151.3 percentage points Trailed |
$10,000 invested in YI 5 years ago (Nov 5, 2021) would be worth about $560 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,694.
All-time high
$273.30
Closing high on . Now 98.9% below that record.
Split-adjusted daily closes since Sep 12, 2018.
Stock splits
1
1-for-10 on . Share counts adjust after each split.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Jun 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
Not reported
Other valuation measures
- 0.0×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - −23.50%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - −$546.89KAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Jun 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own YI DCF in Excel. Value 111 with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $1.51Bdown 23.7%
- Net income
- −$15.27M
- Diluted EPS
- Not reported
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $513.06M | −$2.44M | Not reported |
| Q4 FY24 (Dec 31, 2024) | $527.24M | −$2.72M | Not reported |
| Q1 FY25 (Mar 31, 2025) | $486.33M | −$2.43M | Not reported |
| Q2 FY25 (Jun 30, 2025) | $447.48M | −$2.73M | Not reported |
| Q3 FY25 (Sep 30, 2025) | $421.52M | −$1.82M | Not reported |
| Q4 FY25 (Dec 31, 2025) | $403.11M | −$2.32M | Not reported |
| Q1 FY26 (Mar 31, 2026) | $342.56M | −$5.37M | Not reported |
| Q2 FY26 (Jun 30, 2026) | $338.55M | −$5.76M | Not reported |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $1.95B | −$105.12M | −$12.68 |
| FY22 (Dec 31, 2022) | $1.94B | −$59.87M | −$7.18 |
| FY23 (Dec 31, 2023) | $2.10B | −$55.25M | −$6.56 |
| FY24 (Dec 31, 2024) | $1.97B | −$8.87M | −$1.04 |
| FY25 (Dec 31, 2025) | $1.79B | −$9.49M | −$1.09 |
Margins
- Gross 5.7%
- Operating −0.4%
- Net −1.0%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$5.99MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$5.37MLast 12 months
- Capital spending$624.50KLast 12 months
- −0.4%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- Not reportedLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paidNot reportedLast 12 months
Balance sheet
- $67.11MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$41.50MAs of Jun 30, 2026
- Net cash$25.60MAs of Jun 30, 2026
- 1.07As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio
Financial strength
- 3 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✗Net income was positive: not passed
- ✗Operating cash flow was positive: not passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- −5.1%Last 12 months
Over the last 12 months, 111’s net loss was 5.1% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About 111 Inc
111, Inc. ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.
- Sector
- Consumer Defensive
- Industry
- Pharmaceutical Retailers
- Headquarters
- China
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
YI news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
YI stock FAQ
What is YI stock’s price today?
111 (YI) traded at $2.90 at the close on , down $0.08 (2.68%) from the previous close of $2.98. Over the past 52 weeks it has traded between $2.48 and $11.17.
If you invested $1,000 in YI 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in YI on would be worth about $56 at the close on , a total return of −94.4%. The same $1,000 would be worth $676 if invested one year ago. Past performance doesn’t predict future returns.
What is 111’s market cap?
111’s market capitalization is about $25.5 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $2.90 (how market cap works). 111 reported 175.90M shares outstanding at the end of its latest quarter ().
How much revenue does 111 make?
111 reported $1.5 billion of revenue over the four quarters to , down 23.7% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $338.6 million, down 24.3% from a year earlier.
Is 111 profitable?
Not over the four quarters to . 111 reported a net loss of $15.3 million across those four quarters on $1.5 billion of revenue.
Does YI pay a dividend?
111 hasn’t paid a dividend in the last twelve months.
What is YI’s 52-week high and low?
Over the past 52 weeks YI has traded as low as $2.48 and as high as $11.17. At $2.90 at the close on , it is 74.0% below that high and 16.9% above the low.
What is YI’s all-time high?
YI’s highest closing price was $273.30 on , adjusted for stock splits. At $2.90 at the close on , it is 98.9% below that record.
Has YI stock ever split?
Yes, once: 1-for-10 on .
How has YI stock performed?
Including dividends and measured to the close on , YI has returned +13.3% so far this year and −32.4% over the past year, and −94.4% over five years (−43.8% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is 111 in?
111 is in the Consumer Defensive sector and the Pharmaceutical Retailers industry, and is headquartered in China.
What exchange does YI trade on?
111 trades on the Nasdaq under the ticker symbol YI. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.